Related Experiment Video
Updated: Jun 22, 2025
07:52
Expired CO2 Measurement in Intubated or Spontaneously Breathing Patients from the Emergency Department
Published on: January 29, 2011
16.2K
[High-flow nasal oxygen therapy and hypercapnic acute respiratory failure]
C Girault1, E Artaud-Macari2, G Jolly3
1Service de médecine intensive et réanimation, GRHVN UR-3830, CHU-hôpitaux de Rouen, Normandie univ, 76000 Rouen, France.
Revue Des Maladies Respiratoires
|June 26, 2024
Summary
Humidified high-flow nasal oxygen therapy (HFNO) shows promise for managing hypercapnic acute respiratory failure (ARF), especially in COPD exacerbations. It can be used alone or with non-invasive ventilation (NIV) depending on patient needs.
Area of Science:
- Respiratory Medicine
- Critical Care Medicine
Context:
- Humidified high-flow nasal oxygen therapy (HFNO) is increasingly used for hypoxemic acute respiratory failure (ARF).
- Non-invasive ventilation (NIV) is the standard for hypercapnic ARF.
- The role of HFNO in hypercapnic ARF requires further investigation.
Purpose:
- To explore the potential utility of HFNO in managing hypercapnic ARF.
- To evaluate HFNO's application in acute exacerbations of chronic obstructive pulmonary disease (COPD).
Summary:
- HFNO's physiological effects may benefit patients with hypercapnic ARF.
- HFNO could be an option for initial management or post-extubation in hypercapnic ARF.
- Its use may be continuous or combined with NIV, tailored to ARF severity and cause.
Impact:
- HFNO may offer an alternative or adjunctive therapy for hypercapnic respiratory failure.
- This could improve patient outcomes in COPD exacerbations.
- Further research is needed to establish optimal HFNO protocols for hypercapnic ARF.
Related Concept Videos
01:30Acute Respiratory Failure-III
171
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
171
01:21Acute Respiratory Failure-I
189
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
189
01:29Acute Respiratory Failure-V
130
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
130
01:21Acute Respiratory Failure-II
201
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
201
01:23Acute Respiratory Failure-IV
142
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
142
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
195
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
195